COMMUNIQUÉS West-GlobeNewswire

L’Assemblée Générale Mixte de Cellectis se tiendra le 26 juin 2025
21/05/2025
NEW YORK, 21 mai 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome TALEN® pour développer de [...]
Vaxart Announces Adjournment of Annual Meeting of Stockholders
21/05/2025
Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, [...]
Premier Health Reports 2025 Second Quarter Results
21/05/2025
MONTRÉAL, May 21, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Company ”), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial [...]
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement
21/05/2025
Public offering results in gross proceeds of $57.5 million Private placement results in gross proceeds of approximately $20.3 million GERMANTOWN, Md., May 21, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE [...]
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
21/05/2025
MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence and quality of life [...]
Assemblée Générale Mixte du 21 mai 2025
21/05/2025
Communiqué de presse - Approbation de l’ensemble des résolutions proposées par le Conseil d’administration, y compris les comptes sociaux et les comptes consolidés de l’exercice 2024 - Paris – Le 21 mai 2025 - L’ [...]
Combined General Meeting of May 21, 2025
21/05/2025
Press Release - Approval of all resolutions submitted by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2024 - Paris – May 21, 2025 – The Combined General [...]
OSE Immunotherapeutics annonce une collaboration stratégique sur des technologies pionnières dans le domaine de l’ARNm
21/05/2025
OSE Immunotherapeutics annonce une collaboration stratégique sur des technologies pionnières dans le domaine de l’ARNm OSE Immunotherapeutics, chef de file d’un consortium français aux côtés d’Inside Therapeutics et du [...]
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies
21/05/2025
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies OSE Immunotherapeutics to lead French consortium with Inside Therapeutics and MiNT Laboratory (University of Angers) secures €1 [...]
Ipsen S.A. - Assemblée Générale Annuelle du 21 mai 2025
21/05/2025
Information réglementée Destiné uniquement aux médias internationaux et à la communauté d’investisseurs Assemblée Générale Annuelle d’Ipsen S.A. du 21 mai 2025 Toutes les résolutions soumises au vote des actionnaires [...]
Ipsen S.A. - Annual General Meeting held on 21 May 2025
21/05/2025
Annual General Meeting of Ipsen S.A. held on 21 May 2025 All the resolutions submitted to the shareholders’ vote have been adopted PARIS, FRANCE, 21 May 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announces today that the [...]
Joule Health & Wellbeing Offers Same-Day Stress Support, Providing a Scalable Solution for HR Leaders Addressing Burnout
21/05/2025
Spokane, WA , May 21, 2025 (GLOBE NEWSWIRE) -- In recognition of Mental Health Awareness Month, Joule Health & Wellbeing has expanded its offerings to include same-day stress support —a scalable solution designed to [...]
Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
21/05/2025
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that [...]
Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences
21/05/2025
MINNEAPOLIS, May 21, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief [...]
All Three Leading Proxy Advisory Firms – ISS, Glass Lewis, and Egan-Jones – Recommend Zevra Stockholders Vote FOR the Company’s Director Nominees
21/05/2025
ISS, Glass Lewis, and Egan-Jones Unanimously Conclude Mangless Has Not Made a Compelling Case for Change Board and Management Urge Stockholders to Follow Proxy Advisors’ Recommendation and Vote “FOR” Wendy L. Dixon, Ph. [...]
Soleno Therapeutics to Participate in Upcoming June Conferences
21/05/2025
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced [...]
The Beauty Health Company Announces Convertible Debt Refinancing
21/05/2025
Refinancing extends maturity of existing debt and strengthens Company’s financial position to advance growth strategy LONG BEACH, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to [...]
Galimedix Therapeutics publishes new data in peer-reviewed International Journal of Molecular Sciences demonstrating disease-modifying capability of GAL-201 in Alzheimer’s disease
21/05/2025
Maintains Brain Connectivity: GAL-201 prevents amyloid-beta (Aβ)–induced synaptic damage by maintaining long-term potentiation, a correlate for learning and memory. Improves Memory and Behavior: Preclinical testing [...]
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
21/05/2025
Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery of the super-bore HiPoint 88 Reperfusion System to [...]

Pages